| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
Department of Pharmacology, University of Pittsburgh Drug Discovery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
Requests for reprints: John S. Lazo, Department of Pharmacology, Drug Discovery Institute, Biomedical Science Tower 3, Suite 10040, 3501 Fifth Avenue, University of Pittsburgh, Pittsburgh, PA 15260. Phone: 412-648-9200; Fax: 412-648-9009; E-mail: lazo{at}pitt.edu.
Cdc25 phosphatases propel cell cycle progression by activating cyclin-dependent kinases (Cdk). DNA damage is generally thought to inhibit Cdc25 functionality by inducing proteasomal degradation of Cdc25A and phosphorylation-mediated sequestration of Cdc25B and Cdc25C to the cytoplasm. More recently, a critical role for Cdc25B in the resumption of cell cycle progression through mitosis after DNA damage has been identified. In this study, the fate of Cdc25B after mechanistically distinct DNA-damaging agents (etoposide, cisplatin, bleomycin, ionizing irradiation, or UV irradiation) was examined, and surprisingly a rapid increase in cellular Cdc25B levels was observed after DNA damage. Using UV irradiation as the prototypic damaging agent, we found that the increase in Cdc25B levels was checkpoint dependent and was controlled by a p53-independent mechanism. Cdc25B levels controlled the number of cells progressing into mitosis after UV, but they did not affect G2-M checkpoint engagement immediately after DNA damage. Increased Cdc25B reduced the time required for cell cycle resumption. These data support a model in which Cdc25B accumulation is an important anticipatory event for cell cycle resumption after DNA damage. [Cancer Res 2007;67(7):335663]
This article has been cited by other articles:
![]() |
N. G. Thaker, F. Zhang, P. R. McDonald, T. Y. Shun, M. D. Lewen, I. F. Pollack, and J. S. Lazo Identification of Survival Genes in Human Glioblastoma Cells by Small Interfering RNA Screening Mol. Pharmacol., December 1, 2009; 76(6): 1246 - 1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, X. Zhang, L. Geng, L. Teng, and R. J. Legerski Artemis Regulates Cell Cycle Recovery from the S Phase Checkpoint by Promoting Degradation of Cyclin E J. Biol. Chem., July 3, 2009; 284(27): 18236 - 18243. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Tomko Jr. and J. S. Lazo Multimodal Control of Cdc25A by Nitrosative Stress Cancer Res., September 15, 2008; 68(18): 7457 - 7465. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Srivastava, P. Bansal, T. Oguri, J. S. Lazo, and S. V. Singh Cell Division Cycle 25B Phosphatase Is Essential for Benzo(a)Pyrene-7,8-Diol-9,10-Epoxide Induced Neoplastic Transformation Cancer Res., October 1, 2007; 67(19): 9150 - 9157. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |